• Most Popular
  • Most Shared

Teva wins FDA OK to sell generic Fosamax

Wed Feb 6, 2008 8:59am EST

Stocks

   

CHICAGO, Feb 6 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.O) of Israel said on Wednesday U.S. health authorities approved its generic version of Merck & Co Inc's (MRK.N) osteoporosis treatment Fosamax.

Stocks

The branded product had annual U.S. sales of about $1.9 billion in the 12 months ended Sept. 30, according to IMS sales data.

Teva has been awarded a 180-day period of marketing exclusivity.

The drug, Alendronate Sodium, will be sold in tablets in 5 milligram, 10 mg, 35 mg, 40 mg and 70 mg strengths.

Teva said shipment will begin immediately. (Reporting by Debra Sherman, editing by Gerald E. McCormick)

Stocks


More from Reuters

Photo

Time Warner Cable, Fox at impasse; blackout looms

NEW YORK (Reuters) - About 13 million Time Warner Cable Inc subscribers will lose Fox programing at midnight unless the cable service provider reaches a last-minute deal to pay News Corp fees to broadcast the network's shows.

» More Top News
A picture of an arrow in this file photo. REUTERS/File
OUTLOOK 2010:

The coming Great Inflation

Real or imagined, Americans have plenty of things to worry about. Should inflation be one of them?  Full Article 

ECONOMY
People walk past a branch of Bank of America in New York's financial district April 28, 2009. REUTERS/Brendan McDermid
Rolfe Winkler:

Move your money

Boycotting "too big to fail" banks is a great idea -- so long as investors remember that banks aren't the only ones responsible for the crisis.  Full Article 

    Commentary